OSDPredict™: Get Drug Formulation Right From The Start

Artificial intelligence (AI) and machine learning (ML) are reshaping pharmaceutical development by enabling more informed decisions earlier in the process, reducing reliance on trial-and-error experimentation, and maximizing the use of valuable active pharmaceutical ingredients (APIs). OSDPredict™ is an advanced digital toolbox that leverages AI- and ML-driven models to identify potential formulation and development challenges early, helping sponsors proactively address risks before they evolve into costly delays during scale-up or commercialization.

By providing data-driven insights into critical development considerations—including first-in-human dosing strategies, packaging selection, and manufacturing scale-up—OSDPredict™ helps streamline decision-making and accelerate the path from development to clinical and commercial success. Designed to support small molecule drug development, the platform combines predictive analytics with scientific expertise to improve efficiency, reduce uncertainty, and enable more robust development strategies.

This fact sheet provides an overview of OSDPredict™ and its capabilities, including the AI and ML models that power its predictions, the benefits of integrating predictive tools into development programs, and how these insights can support formulation, manufacturing, and commercialization planning. It also highlights how Thermo Fisher Scientific's integrated small molecule development expertise complements digital innovation to help sponsors advance therapies with greater speed and confidence.

Download the fact sheet to learn how OSDPredict™ can help identify risks earlier, optimize development strategies, and support more successful outcomes across the drug development lifecycle.